CIK: 1390798 - Address: C/o Avadel Pharmaceuticals Plc, 10 Earlsfort Terrace, Dublin 2, L2 D02 T380
22 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
12/29/23 16:15
12/28/23
AVDLAvadel Pharmaceuticals PlcHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyL2DS-1,09014.530-75-5367I
8/15/23 16:13
8/11/23
AVDLAvadel Pharmaceuticals PlcHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyL2DS-43314.930-29-17142I
9/18/20 16:20
9/16/20
AVDLAvadel Pharmaceuticals PlcHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyL2DP.m9855.760171New171I
4/3/20 17:50
4/1/20
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyCADOP,CEOM.d1484.880305D
4/3/20 17:50
4/1/20
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyCADOP,CEOS.d-3,10995.420-33-885D
6/27/19 18:22
6/25/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyCADOP,CEOM.d404.88081661D
6/27/19 18:22
6/25/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyCADOP,CEOS.d-9011.020-8-1261D
6/24/19 17:39
6/20/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyCADOP,CEOM.d414.88081661D
6/24/19 17:39
6/20/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyCADOP,CEOS.d-9211.040-8-1261D
5/22/19 20:15
5/20/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyCADOP,CEOM.d814.880173761D
5/22/19 20:15
5/20/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyCADOP,CEOS.d-20012.100-17-2161D
4/22/19 20:21
4/18/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyCADOP,CEOM.d814.880173761D
4/22/19 20:21
4/18/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyCADOP,CEOS.d-29918.120-17-2161D
3/21/19 20:42
3/19/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyCADOP,CEOM.d814.880173761D
3/21/19 20:42
3/19/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyCADOP,CEOS.d-29918.150-17-2161D
2/21/19 19:51
2/19/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyCADOP,CEOM.dm814.880173761D
2/21/19 19:51
2/19/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyCADOP,CEOS.dm-24714.990-17-2161D
1/29/19 19:38
1/25/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyCADOP,CEOM.d2524.8805257261D
1/23/19 19:42
1/18/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyCADOP,CEOM.d984.880209D
1/23/19 19:42
1/18/19
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyCADOP,CEOS.d-29214.590-20-699D
12/28/18 17:37
12/26/18
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyCADOP,CEOM.d594.880129D
12/28/18 17:37
12/26/18
FTSVForty Seven, Inc.DEHealthDrugPharmaceutical PreparationsMcCamish Mark AnthonyCADOP,CEOS.d-19115.900-12-579D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact